SCHEMBL7367916

SCHEMBL7367916

Cc1ccc2oc(=O)c(-c3cc(OC(=O)C(C)C)c(OC(=O)C(C)C)c([N+](=O)[O-])c3)nc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP2 P08253 2/20 0.40
MMP9 P14780 2/20 0.40
MMP8 P22894 2/20 0.40
MMP13 P45452 2/20 0.40
GAA P10253 7/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
MAPT P10636 6/20 0.37
MAOB P27338 4/20 0.37
MAOA P21397 1/20 0.35
KDM4E B2RXH2 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ALDH1A1 P00352 4/20 0.34
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
CRHBP P24387 2/20 0.34
CRHR2 Q13324 2/20 0.34
ALOX5 P09917 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7375625 0.87 MMP2 (0.40) MMP2MMP9MMP8MMP13GAA
SCHEMBL8733159 0.87 ALDH1A1 (0.35) SMN1; SMN2MAPTMAOBMAOAALDH1A1
SCHEMBL7372530 0.85 MAPT (0.43) MMP2MMP9MMP8MMP13GAA
SCHEMBL7370121 0.77 MAPT (0.43) MMP2MMP9MMP8MMP13GAA
SCHEMBL7371467 0.77 ELANE (0.35) SMN1; SMN2MAPTKDM4ETP53TSHR
SCHEMBL7373423 0.76 MMP2 (0.47) MMP2MMP9MMP8MMP13GAA
SCHEMBL7371469 0.76 MAPT (0.36) GAASMN1; SMN2MAPTKDM4EMEN1
SCHEMBL7369595 0.73 HPGD (0.46) GAAMAPTKDM4EMEN1KMT2A
SCHEMBL7367777 0.71 MAPT (0.54) GAASMN1; SMN2MAPTKDM4EMEN1
SCHEMBL24858664 0.69 TTR (0.53) GAASMN1; SMN2MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed